GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

CELLDEX THERAPEUTICS, INC (CLDX) CEO Anthony S Marucci buys 12,000 Shares

September 13, 2010 | About:
insider

insider

57 followers
President & CEO of CELLDEX THERAPEUTICS, INC (CLDX) Anthony S Marucci buys 12,000 shares of CLDX on 09/10/2010 at an average price of $3.45 a share.

Celldex Therapeutics, Inc has a market cap of $111.29 million; its shares were traded at around $3.49 with and P/S ratio of 7.33.

CLDX is in the portfolios of Paul Tudor Jones of The Tudor Group.

CFO Recent Trades:



  • Buy: Sr. VP & CFO Avery W Catlin bought 2,000 shares of CLDX stock on 09/08/2010 at the average price of 3.51. Avery W Catlin owns at least 2,000 shares after this. The price of the stock has decreased by 0.57% since.



This is the insider trade history vs. stock price of CLDX. For the complete insider trading history of CLDX, click here.




Directors and Officers Recent Trades:



  • Buy: Director Timothy M Shannon bought 5,000 shares of CLDX stock on 09/10/2010 at the average price of 3.41. Timothy M Shannon owns at least 100 shares after this. The price of the stock has increased by 2.35% since.
  • Buy: Director Harry Jr Penner bought 3,000 shares of CLDX stock on 09/09/2010 at the average price of 3.49. Harry Jr Penner owns at least 3,000 shares after this. The price of the stock has decreased by 0% since.
  • Buy: Director Charles R Schaller bought 5,000 shares of CLDX stock on 09/09/2010 at the average price of 3.45. Charles R Schaller owns at least 5,000 shares after this. The price of the stock has increased by 1.16% since.


About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 1.7/5 (3 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK